Long-term Outcomes in Patients with Progressive MS with Relapses: Analysis of TEMSO and TOWER Extension Data

被引：0
|
作者：
Nelson, Flavia [1 ]
Lebrun-Frenay, Christine [2 ]
Camu, William [3 ]
Boyko, Alexey [4 ]
Thangavelu, Karthinathan [5 ]
Rufi, Pascal [5 ]
Cavalier, Steve [5 ]
Truffinet, Philippe [5 ]
Liang, Jinjun [5 ]
Lublin, Fred [6 ]
机构：
[1] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA
[2] Hop Louis Pasteur, Nice, France
[3] Inst Neurosci Montpellier, Montpellier, France
[4] Russian State Med Univ, Usupovs Hosp, Neuroclin, Moscow, Russia
[5] Sanofi Genzyme, Cambridge, MA USA
[6] Mt Sinai Sch Med, New York, NY USA
来源：
NEUROLOGY | 2017年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S33.008
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Outcomes in Patients with Progressive MS: Analysis of Teriflunomide Long-Term Extension Data
    Nelson, Flavia
    Lebrun-Frenay, Christine
    Camu, William
    Boyko, Alexey
    Thangavelu, Karthinathan
    Rufi, Pascal
    Cavalier, Steve
    Truffinet, Philippe
    Liang, Jinjun
    Lublin, Fred
    [J]. NEUROLOGY, 2016, 86
  • [2] Impact of Long-term Teriflunomide Treatment on Severe Relapses: Analysis of TEMSO and TOWER Extensions
    Maeurer, Mathias
    Miller, Aaron
    Comi, Giancarlo
    Kappos, Ludwig
    Wolinsky, Jerry
    Stange, Martin
    Macdonell, Richard
    Truffinet, Philippe
    Thangavelu, Karthinathan
    Freedman, Mark
    [J]. NEUROLOGY, 2017, 88
  • [3] Long-term outcomes in patients with progressive forms of relapsing MS treated with teriflunomide: patient-level data from the TEMSO and TOWER extension studies and the real-world setting
    Nelson, F.
    Lebrun-Frenay, C.
    Camu, W.
    Boyko, A.
    Thangavelu, K.
    Mandel, M.
    Cavalier, S.
    Truffinet, P.
    Liang, J.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 940 - 941
  • [4] Baseline characteristics and long-term disability outcomes: subgroup analysis of the TEMSO and TOWER core and extension studies
    Vermersch, P.
    Truffinet, P.
    Poole, E. M.
    Mandel, M.
    Freedman, M. S.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 629 - 630
  • [5] Long-term outcomes in patients with progressive forms of relapsing MS treated with teriflunomide: Patient-level data from the TEMSO and TOWER extension studies and the real-world setting
    Nelson, Flavia
    Boyko, Alexey
    Thangavelu, Karthinathan
    Mandel, Matt
    Cavalier, Steven
    Truffinet, Philippe
    Liang, Jinjun
    Lebrun-Frenay, Christine
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (01) : 145 - 145
  • [6] Long-term Disability Outcomes in Teriflunomide-Treated Patients in TEMSO and TOWER: An Analysis Utilizing the Topographical Model of MS
    Krieger, Stephen
    Freedman, Mark S.
    Miller, Aaron E.
    Truffinet, Philippe
    Thangavelu, Karthinathan
    Mandel, Matt
    Lublin, Fred
    [J]. NEUROLOGY, 2018, 90
  • [7] Long-term Efficacy and Safety Outcomes of Teriflunomide Treatment in TEMSO and TOWER
    Oh, Jiwon
    Freedman, Mark S.
    Benamor, Myriam
    Poole, Elizabeth
    Chavin, Jeffrey
    Comi, Giancarlo
    [J]. NEUROLOGY, 2018, 90
  • [8] Predicting long-term disability outcomes in patients with MS treated with teriflunomide in TEMSO
    Sormani, Maria Pia
    Truffinet, Philippe
    Thangavelu, Karthinathan
    Rufi, Pascal
    Simonson, Catherine
    De Stefano, Nicola
    [J]. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2017, 4 (05):
  • [9] Long-term disability outcomes in teriflunomide-treated patients in TEMSO and TOWER: an EDSS and FSS categorical analysis
    Lublin, F.
    Miller, A.
    Truffinet, P.
    Thangavelu, K.
    Mandel, M.
    Freedman, M. S.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 903 - 903
  • [10] Benefit of long-term treatment with teriflunomide on disability outcomes: results from TEMSO and TOWER
    Lublin, F.
    Freedman, M. S.
    Comi, G.
    Miller, A. E.
    Thangavelu, K.
    Truffinet, P.
    Kappos, L.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 333 - 334
12345